As the overexpression of TGM2 in cancer cells is usually linked to transcription level changes of cancer-related genes, TGM2-mediated histone monoaminylation may serve as a key upstream regulation mechanism to manipulate gene transcription in an epigenetic fashion. The gene discussed is TGM2; the disease is cancer.